InVivo Therapeutics Holdings Corp. (NVIV): Price and Financial Metrics
GET POWR RATINGS... FREE!
NVIV Stock Price Chart Interactive Chart >
NVIV Price/Volume Stats
|Current price||$7.98||52-week high||$16.50|
|Prev. close||$4.36||52-week low||$3.50|
|Day high||$7.98||Avg. volume||253,359|
|50-day MA||$6.01||Dividend yield||N/A|
|200-day MA||$6.94||Market Cap||11.10M|
InVivo Therapeutics Holdings Corp. (NVIV) Company Bio
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 and is based in Cambridge, Massachusetts.
Most Popular Stories View All
NVIV Latest News Stream
|Loading, please wait...|
NVIV Latest Social Stream
View Full NVIV Social Stream
Latest NVIV News From Around the Web
Below are the latest news stories about INVIVO THERAPEUTICS HOLDINGS CORP that investors may wish to consider to help them evaluate NVIV as an investment opportunity.
Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday!
InVivo Therapeutics (NVIV) stock is rocketing higher on Thursday despite a lack of news concerning the biotechnology company.
InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel
CAMBRIDGE, Mass., July 13, 2022--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced the appointment of Heather M. Hamel, J.D. as its Chief Legal Officer and General Counsel. In her role, Ms. Hamel will lead the company’s legal and intellectual property functions, and provide strategic guidance to the company’s Board of Directors and executive management team
NVIV Price Returns